Abstract
Benign prostatic hypertrophy (BPH) is a common disorder of elderly men, affecting about 80% of men by the age of 80. Until recently, therapeutic options were limited, and transurethral surgery was the most common remedy. In recent years, however, a number of alternatives to traditional surgery have evolved. This article reviews and evaluates current medical and nonmedical therapies for BPH.
MeSH terms
-
Aged
-
Androgen Antagonists / pharmacology
-
Androgen Antagonists / therapeutic use
-
Catheterization / psychology
-
Catheterization / standards
-
Catheterization / statistics & numerical data
-
Consumer Behavior
-
Estrogens / pharmacology
-
Estrogens / therapeutic use
-
Gonadotropin-Releasing Hormone / analogs & derivatives
-
Humans
-
Male
-
Prostatic Hyperplasia / drug therapy
-
Prostatic Hyperplasia / physiopathology
-
Prostatic Hyperplasia / surgery*
-
Urethra / surgery
Substances
-
Androgen Antagonists
-
Estrogens
-
Gonadotropin-Releasing Hormone